Pàgina inicial > Resultats de la cerca: Caleiras, Eduardo
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 2 registres trobats en 0.01 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
1.
11 p, 673.6 KB DLST mutations in pheochromocytoma and paraganglioma cause proteome hyposuccinylation and metabolic remodeling / Mellid, Sara (Hereditary Endocrine Cancer Group. Spanish National Cancer Research Centre) ; García, Fernando (Proteomics Unit. Spanish National Cancer Research Centre) ; Leandro-García, Luís Javier (Hereditary Endocrine Cancer Group. Spanish National Cancer Research Centre) ; Díaz-Talavera, Alberto (Centro de Investigación Biomédica en Red de Enfermedades Raras) ; Martínez-Montes, Ángel Mario (Hereditary Endocrine Cancer Group. Spanish National Cancer Research Centre) ; Gil, Eduardo (Hereditary Endocrine Cancer Group. Spanish National Cancer Research Centre) ; Calsina, Bruna (Hereditary Endocrine Cancer Group. Spanish National Cancer Research Centre) ; Monteagudo, María (Hereditary Endocrine Cancer Group. Spanish National Cancer Research Centre) ; Letón, Rocío (Hereditary Endocrine Cancer Group. Spanish National Cancer Research Centre) ; Roldán-Romero, Juan María (Hereditary Endocrine Cancer Group. Spanish National Cancer Research Centre) ; Santos, María (Hereditary Endocrine Cancer Group. Spanish National Cancer Research Centre) ; Lanillos, Javier (Hereditary Endocrine Cancer Group. Spanish National Cancer Research Centre) ; Valdivia, Carlos (Hereditary Endocrine Cancer Group. Spanish National Cancer Research Centre) ; Martínez-Puente, Natalia (Centro de Investigación Biomédica en Red de Enfermedades Raras) ; de Nicolás-Hernández, Javier (Hereditary Endocrine Cancer Group. Spanish National Cancer Research Centre) ; Jiménez,Scherezade (Monoclonal Antibodies Core Unit. Spanish National Cancer Research Centre) ; Pérez-Martínez, Manuel (Confocal Microscopy Core Unit. Spanish National Cancer Research Centre) ; Honrado, Emiliano (Anatomical Pathology Service. Hospital of León) ; Coloma, Javier (Structural Biology Programme. Spanish National Cancer Research Centre) ; Cerezo, Ana (CNIO-Lilly Cell Signalling and Immunometabolism Section. Spanish National Cancer Research Centre) ; Santiveri, Clara María (Spectroscopy and Nuclear Magnetic Resonance Unit. Spanish National Cancer Research Centre) ; Esteller, M (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Campos-Olivas, Ramón (Spectroscopy and Nuclear Magnetic Resonance Unit. Spanish National Cancer Research Centre) ; Caleiras, Eduardo (Histopathology Core Unit. Spanish National Cancer Research Centre) ; Montero-Conde, Cristina (Hereditary Endocrine Cancer Group. Spanish National Cancer Research Centre) ; Rodríguez-Antona, Cristina (Hereditary Endocrine Cancer Group. Spanish National Cancer Research Centre) ; Muñoz, Javier (Ikerbasque. Basque Foundation for Science) ; Robledo, Mercedes (Centro de Investigación Biomédica en Red de Enfermedades Raras) ; Cascón, Alberto (Centro de Investigación Biomédica en Red de Enfermedades Raras)
2023 - 10.1002/cac2.12427
Cancer Communications, Vol. 43 Núm. 7 (july 2023) , p. 838-843  
Registre complet - Creative Commons
2.
14 p, 1.4 MB Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer : a pilot clinical trial / Quintela-Fandino, Miguel (Hospital Universitario Quiron. Medical Oncology Department) ; Holgado, Esther (Hospital Universitario Ramón y Cajal (Madrid)) ; Manso, Luis (Hospital Universitario 12 de Octubre (Madrid)) ; Morales, Serafin (Hospital Arnau de Vilanova (València)) ; Bermejo, Begoña (Centro de Investigación Biomédica en Red de Cáncer) ; Colomer, Ramon (Universidad Autónoma de Madrid. Facultad de Medicina) ; Apala, Juan V. (Hospital Universitario de Fuenlabrada ( Madrid)) ; Blanco, Raquel (Centro Nacional de Biotecnología/CSIC. Department of Immunology and Oncology) ; Muñoz, Manuel (Breast Cancer Clinical Research Unit - Clinical Research Program, CNIO - Spanish National Cancer Research Center) ; Caleiras, Eduardo (Histopathology Core Unit - Biotechnology Program, CNIO - Spanish National Cancer Research Center) ; Iranzo, Vega (Universitat de València. Departament de Medicina) ; Martínez López, Mario (Hospital Universitario 12 de Octubre (Madrid)) ; Dominguez, Orlando (Genomics Core Unit - Biotechnology Program, CNIO - Spanish National Cancer Research Center) ; Hornedo, Javier (Hospital Universitario Quiron. Medical Oncology Department) ; Gonzalez-Cortijo, Lucia (Hospital Universitario Quiron. Medical Oncology Department) ; Cortés, Javier (Vall d'Hebron Institut d'Oncologia) ; Gasol Cudos, Ariadna (Hospital Arnau de Vilanova (València)) ; Malon, Diego (Hospital Universitario de Fuenlabrada ( Madrid)) ; Lopez-Alonso, Antonio (Spanish National Cancer Research Center) ; Moreno-Ortíz, María C. (Centro Nacional de Biotecnología/CSIC) ; Mouron, Silvana (Spanish National Cancer Research Center) ; Mañes, Santos (Centro Nacional de Biotecnología/CSIC) ; Universitat Autònoma de Barcelona
Preclinical research suggests that the efficacy of immune checkpoint inhibitors in breast cancer can be enhanced by combining them with antiangiogenics, particularly in a sequential fashion. We sought to explore the efficacy and biomarkers of combining the anti-PD-L1 durvalumab plus the antiangiogenic bevacizumab after bevacizumab monotherapy for advanced HER2-negative breast cancer. [...]
2020 - 10.1186/s13058-020-01362-y
Breast cancer research, Vol. 22 (november 2020)  
Registre complet - Creative Commons

Vegeu també: autors amb noms similars
1 Caleiras, E.
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem